Personalized Drug Screening on the Horizon for Multiple Myeloma Patients (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)

A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer. The process, developed by scientists at Washington University School of Medicine in St. Louis, also may aid patients with leukemia or lymphoma. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news